Midcap Q2FY22 Earnings Preview - Growth Intact; Sequential Margin Pressure In Chemicals: Nirmal Bang
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Nirmal Bang Research Report
We present Q2 FY22 preview for our mid-cap coverage universe. We have divided our coverage into three sections:
specialty Ingredients and
Overall, we believe that the strong growth trajectory would be maintained in specialty chemicals as well as specialty ingredients.
In select cases, pick-up in the domestic market would further lead to an improvement.
However, we expect the rising cost of inputs, freight and power will result in sequential margin decline in specialty chemicals coverage universe.
Our specialty Ingredients coverage universe is expected to deliver strong revenue growth, especially Oleochemicals companies.
In out other mid-cap universe CCL Products India Ltd.’s growth would be led by India operations as Vietnam might witness a decline on account of lockdown restrictions from August 2021 and a very strong base.
Click on the attachment to read the full report:
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.